Richard Karroum

Richard Karroum serves as CEO at EVOLAN PHARMA AB. EVOLAN PHARMA AB operates in the pharmaceuticals sector with approximately 35.0 employees. The company is headquartered in Stockholm County.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 2,710 executive contacts are available in Stockholm County.
• • Our database includes 201,468 c suite-level executives.

Outlook Microsoft Office 365 Google Font API Nginx Mobile Friendly WordPress.org

pharmaceutical manufacturing prescription drugs over-the-counter medications product development marketing partnerships urology erectile dysfunction drug safety quality assurance chronic venous insufficiency nafazoline sodium hyaluronate active ingredients clinical studies drug registration drug launch medical devices therapeutic areas patient safety supply chain management strategic alliances cleansing formulations medical treatments healthcare solutions natural remedies fda regulations gmp compliance drug formulation personal care products patient education online pharmacy medical packaging therapeutic effectiveness research & development clinical trials monograph standards zinc oxide itch relief alleviation of symptoms eye care moisturizing drops local treatment inflammation reduction product efficacy multi-national collaborations regulatory compliance sustainability in pharma healthcare partnerships innovative therapies pharmaceuticals medical hospital & health care logistics & supply chain health care health wellness & fitness

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Richard Karroum in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at EVOLAN PHARMA AB.

Richard Karroum's Position in the MessageCEO Database

• •Richard Karroum is 1 of 1 verified executive contact we track at EVOLAN PHARMA AB.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •2,690 verified executive contacts in Stockholm County are in the database.
• •14 verified contacts work at pharmaceuticals companies in the 35.0 employee range (same size as EVOLAN PHARMA AB).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Richard Karroum directly?

Richard Karroum's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at EVOLAN PHARMA AB. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Richard Karroum work for?

Richard Karroum is CEO at EVOLAN PHARMA AB, a company in the pharmaceuticals sector with 35.0 employees. The company is based in Stockholm County.

Can I pitch or sell to Richard Karroum?

As CEO at EVOLAN PHARMA AB, Richard Karroum is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Richard Karroum directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Richard Karroum in?

Richard Karroum works in the pharmaceuticals industry as CEO at EVOLAN PHARMA AB. MessageCEO provides verified contact information for executives across all major industries.

Is Richard Karroum's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Richard Karroum's profile is kept up-to-date with the latest available information.

Last updated: July 30, 2026